Washington Osorio
Research Subjects
Washington Osorio has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Santiago David Silva Tobar
Servicio de Nefrología, Hospital General Docente Ambato-Ecuador
3 shared publications - Alfonso Silva Contreras
Contigo S.A. Dialicon Quito, Ecuador
2 shared publications - David Garrido
Hospital de clínicas Dr. Manuel Quintela, Montevideo, Uruguay
2 shared publications - Franklin Mora-Bravo
Hemodiafiltration Unit, Pafram Hemodiafiltration Unit, Sucúa, ECU
2 shared publications - Jorge Rico-Fontalvo
Universidad Simón Bolívar, Barranquilla, Colombia
2 shared publications - Juan Carlos Paz Veloz
Servicio de Nefrología, Hospital Militar Guayaquil, Ecuador
2 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (2) , 172-187
Perfil epidemiológico de las glomerulopatías en adultos
Introduction: This cross-sectional study aims to determine the prevalence of different types of glomerulopathy among patients aged 18 years or older who underwent renal biopsy at the Metropolitan Hospital of Quito from January 2019 to August 2024. Materials and methods: Reports of renal biopsies performed between January 2019 and August 2024 were reviewed. All adult patients aged 18 years or older who underwent a renal biopsy during this period were included. Histological diagnoses were classified according to the World Health Organization (WHO) classification, and their overall prevalence was evaluated, as well as their prevalence by gender and age. Results: A total of 168 renal biopsies were analyzed, revealing a gender distribution of 58.33% male and 41.67% female, with a mean age of 46.81 ± 16.79 years. The most frequent glomerulopathy was focal segmental glomerulosclerosis (FSGS), with a prevalence of 22.49% across all age groups. Other common diagnoses included IgA nephropathy and membranous glomerulonephritis, both with a prevalence of 13.1%. Among those under 40 years of age, lupus nephritis was the most prevalent at 22.54%, whereas among those over 65 years of age, FSGS was the most prevalent at 31.25%. Additionally, lupus nephritis (27.14%) was more prevalent in women compared to men, who presented with focal segmental glomerulosclerosis (25.56%). Conclusions: Primary glomerulopathies are the third leading cause of chronic kidney disease worldwide. These conditions are potentially treatable if diagnosed early, which can prevent their progression and the subsequent need for dialysis. This study provides valuable information on the distribution and prevalence of glomerulopathies, which is essential for improving diagnosis and treatment in our setting.
- 4 March 2026
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (2) , 172-187
Open AccessPerfil epidemiológico de las glomerulopatías en adultos
Introduction: This cross-sectional study aims to determine the prevalence of different types of glomerulopathy among patients aged 18 years or older who underwent renal biopsy at the Metropolitan Hospital of Quito from January 2019 to August 2024. Materials and methods: Reports of renal biopsies performed between January 2019 and August 2024 were reviewed. All adult patients aged 18 years or older who underwent a renal biopsy during this period were included. Histological diagnoses were classified according to the World Health Organization (WHO) classification, and their overall prevalence was evaluated, as well as their prevalence by gender and age. Results: A total of 168 renal biopsies were analyzed, revealing a gender distribution of 58.33% male and 41.67% female, with a mean age of 46.81 ± 16.79 years. The most frequent glomerulopathy was focal segmental glomerulosclerosis (FSGS), with a prevalence of 22.49% across all age groups. Other common diagnoses included IgA nephropathy and membranous glomerulonephritis, both with a prevalence of 13.1%. Among those under 40 years of age, lupus nephritis was the most prevalent at 22.54%, whereas among those over 65 years of age, FSGS was the most prevalent at 31.25%. Additionally, lupus nephritis (27.14%) was more prevalent in women compared to men, who presented with focal segmental glomerulosclerosis (25.56%). Conclusions: Primary glomerulopathies are the third leading cause of chronic kidney disease worldwide. These conditions are potentially treatable if diagnosed early, which can prevent their progression and the subsequent need for dialysis. This study provides valuable information on the distribution and prevalence of glomerulopathies, which is essential for improving diagnosis and treatment in our setting.
- Open Access
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 130-132
Valoración ultrasonográfica de la congestión venosa - VExUS
Doppler of the hepatic vein with a monophasic pulsatile pattern with systolic inversion, compatible with elevation of right atrial pressure and with significant systemic venous congestion. - inversion or marked decrease in the systolic wave. - Diastolic predominance. - Retrograde flow episodes. - Very pulsatile morphology. - great variability with the cardiac cycle. In practical terms: S < D S reverse.
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 130-132
Open AccessValoración ultrasonográfica de la congestión venosa - VExUS
Doppler of the hepatic vein with a monophasic pulsatile pattern with systolic inversion, compatible with elevation of right atrial pressure and with significant systemic venous congestion. - inversion or marked decrease in the systolic wave. - Diastolic predominance. - Retrograde flow episodes. - Very pulsatile morphology. - great variability with the cardiac cycle. In practical terms: S < D S reverse.
- Open Access
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 39-49
Autodeterminación en salud, como factor psicológico que influye en la supervivencia observacional y en la percepción de síntomas en pacientes en programas de hemodiálisis
Introduction: Self-determination in Health (SDH), defined as a patient's inherent ability to make informed and active decisions about their health care, is a modifiable psychological factor that correlates with motivation, proactive behavior, and improved physical health outcomes. In the context of hemodialysis (HD) therapy, SDH promotes functional autonomy and active patient engagement, even in the face of vulnerability; by contrast, its absence is associated with decision delegation and deterioration in health. The study hypothesizes that patients in hemodialysis programs with higher SDH will have a lower perception of symptoms and a longer survival. Methods: This observational, case-control study was carried out in 14 hemodialysis units in Ecuador from May to June 2025. Patients aged 18 years or older who were enrolled in hemodialysis programs were included. Two groups were formed: one with patients without SDH and the other with patients with SDH. The variables studied included age, duration of hemodialysis treatment, self-determination in health, adherence to treatment, labor integration, physical dependence, acceptance of kidney disease, and scores on "The Dialysis Symptom Index." A 1:1 propensity score matching (PSM) was performed between the groups based on age, sex, and presence of type 2 diabetes mellitus. The means were compared using Student's t-test, while proportions were compared using Chi-squared tests. An observational survival analysis was also conducted, examining the length of stay in the hemodialysis unit up to the date of the survey. Results: 180 patients without SDH and 184 with SDH were analyzed. Age was similar in both groups (57.9 ± 13.7 years vs. 58.0 ± 11.8 years, P = 0.938). The proportion of men was similar in both groups (51.1% vs. 51.6%; P=0.921). The prevalence of type 2 diabetes mellitus was comparable between the groups (48.3% vs. 47.3%; P=0.841). The group without SDH had a higher rate of physical dependence (53.3%) compared to the group with SDH (25.5%) (P < 0.001). Adherence was greater in the group with SDH (51.6%) than in the group without SDH (36.7%; P < 0.001). Work activity was more common among the group with SDH (38.0%) compared to 12.2% among the group without SDH (12.2%; P < 0.001). The group with SDH showed lower symptom intensity (–25.82%) than the group without SDH (P<0.001). Increased survival was observed in the SDH group, with 29.5 months versus 36.08 months in the non-SDH group (χ2, Log-Rank 7.71, P<0.005). Conclusions: Patients with SDH exhibited longer survival, significantly higher treatment adherence, and less physical dependence. Additionally, self-determination was associated with a reduction in the severity of perceived symptoms, including pain and psychological symptoms such as worry and sadness, across 18 of the 34 assessed. These findings demonstrate that SDH is not just a psychological concept but also a therapeutic goal that impacts survival. Randomized intervention studies in SDH are necessary.
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 39-49
Open AccessAutodeterminación en salud, como factor psicológico que influye en la supervivencia observacional y en la percepción de síntomas en pacientes en programas de hemodiálisis
Introduction: Self-determination in Health (SDH), defined as a patient's inherent ability to make informed and active decisions about their health care, is a modifiable psychological factor that correlates with motivation, proactive behavior, and improved physical health outcomes. In the context of hemodialysis (HD) therapy, SDH promotes functional autonomy and active patient engagement, even in the face of vulnerability; by contrast, its absence is associated with decision delegation and deterioration in health. The study hypothesizes that patients in hemodialysis programs with higher SDH will have a lower perception of symptoms and a longer survival. Methods: This observational, case-control study was carried out in 14 hemodialysis units in Ecuador from May to June 2025. Patients aged 18 years or older who were enrolled in hemodialysis programs were included. Two groups were formed: one with patients without SDH and the other with patients with SDH. The variables studied included age, duration of hemodialysis treatment, self-determination in health, adherence to treatment, labor integration, physical dependence, acceptance of kidney disease, and scores on "The Dialysis Symptom Index." A 1:1 propensity score matching (PSM) was performed between the groups based on age, sex, and presence of type 2 diabetes mellitus. The means were compared using Student's t-test, while proportions were compared using Chi-squared tests. An observational survival analysis was also conducted, examining the length of stay in the hemodialysis unit up to the date of the survey. Results: 180 patients without SDH and 184 with SDH were analyzed. Age was similar in both groups (57.9 ± 13.7 years vs. 58.0 ± 11.8 years, P = 0.938). The proportion of men was similar in both groups (51.1% vs. 51.6%; P=0.921). The prevalence of type 2 diabetes mellitus was comparable between the groups (48.3% vs. 47.3%; P=0.841). The group without SDH had a higher rate of physical dependence (53.3%) compared to the group with SDH (25.5%) (P < 0.001). Adherence was greater in the group with SDH (51.6%) than in the group without SDH (36.7%; P < 0.001). Work activity was more common among the group with SDH (38.0%) compared to 12.2% among the group without SDH (12.2%; P < 0.001). The group with SDH showed lower symptom intensity (–25.82%) than the group without SDH (P<0.001). Increased survival was observed in the SDH group, with 29.5 months versus 36.08 months in the non-SDH group (χ2, Log-Rank 7.71, P<0.005). Conclusions: Patients with SDH exhibited longer survival, significantly higher treatment adherence, and less physical dependence. Additionally, self-determination was associated with a reduction in the severity of perceived symptoms, including pain and psychological symptoms such as worry and sadness, across 18 of the 34 assessed. These findings demonstrate that SDH is not just a psychological concept but also a therapeutic goal that impacts survival. Randomized intervention studies in SDH are necessary.
- Open Access
- 3 March 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 13 (2) , 91-97
Prevalence of multiple myeloma in patients on hemodialysis programs
Introduction: Multiple myeloma (MM) is a hematological malignancy that often causes kidney failure, affecting more than 50% of MM patients. Kidney damage in MM is primarily due to cast nephropathy, light chain deposition disease, and amyloidosis. However, there are no data on MM patients undergoing hemodialysis in Ecuador. This study aims to report the prevalence of MM in the country's hemodialysis units. Methods: This observational, descriptive, cross-sectional, multicenter study evaluated the prevalence of MM in hemodialysis patients in Ecuador. A survey was distributed to 23 nephrologists, collecting data on the total number of hemodialysis patients and those diagnosed with MM. Prevalence was calculated using the formula: Prevalence = (MM patients / Total hemodialysis patients) × 1000. Data were analyzed using nonparametric methods in R v4.3.2, with 99% confidence intervals. Results: were diagnosed with MM, yielding a prevalence of 1.1% (95% CI: 0.7% to 1.6%), or 11.3 cases per 1000 hemodialysis patients. The number of MM cases varied by city, with the highest number reported in Portoviejo (10 cases) and none in Riobamba. Conclusion: The prevalence of MM in Ecuador is consistent with international reports, with similar findings in the United States (1.0%), Nigeria (0.81%), and other Latin American countries. These findings highlight the need for a national registry to better understand the needs of MM patients on hemodialysis.
- 3 March 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 13 (2) , 91-97
Open AccessPrevalence of multiple myeloma in patients on hemodialysis programs
Introduction: Multiple myeloma (MM) is a hematological malignancy that often causes kidney failure, affecting more than 50% of MM patients. Kidney damage in MM is primarily due to cast nephropathy, light chain deposition disease, and amyloidosis. However, there are no data on MM patients undergoing hemodialysis in Ecuador. This study aims to report the prevalence of MM in the country's hemodialysis units. Methods: This observational, descriptive, cross-sectional, multicenter study evaluated the prevalence of MM in hemodialysis patients in Ecuador. A survey was distributed to 23 nephrologists, collecting data on the total number of hemodialysis patients and those diagnosed with MM. Prevalence was calculated using the formula: Prevalence = (MM patients / Total hemodialysis patients) × 1000. Data were analyzed using nonparametric methods in R v4.3.2, with 99% confidence intervals. Results: were diagnosed with MM, yielding a prevalence of 1.1% (95% CI: 0.7% to 1.6%), or 11.3 cases per 1000 hemodialysis patients. The number of MM cases varied by city, with the highest number reported in Portoviejo (10 cases) and none in Riobamba. Conclusion: The prevalence of MM in Ecuador is consistent with international reports, with similar findings in the United States (1.0%), Nigeria (0.81%), and other Latin American countries. These findings highlight the need for a national registry to better understand the needs of MM patients on hemodialysis.
- Open Access
- 6 June 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (2) , 175-182
Factores asociados a falla en la desconexión de pacientes con terapia de reemplazo renal continuo.
Introduction: Critically ill patients who survive a severe episode of Acute Kidney Injury (AKI) recover sufficient renal function to allow withdrawal of Renal Replacement Therapy (RRT). However, the criteria for deciding its withdrawal need to be standardized in clinical practice. The study aimed to determine the factors associated with failure to disconnect in patients on continuous renal replacement therapy. Methods: This observational study was carried out in adult patients hospitalized in the intensive care service of the National Institute of Nutrition "Salvador Zubirán" in Mexico between October and December 2023 who required continuous renal replacement therapy. Retrospective data were collected, including demographic characteristics, comorbidities, type of renal replacement therapy, and clinical outcome. The SOFA score was used to assess disease severity. Results: A total of 18 patients were analyzed, 14 with unsuccessful disconnection and 4 with successful disconnection, with an average stay of 14±8 days in the ICU; 72% were men, 44% with a history of diabetes, and 72.2% with a history of high blood pressure. A total of 94.4% with vasopressor requirement and invasive mechanical ventilation. The primary RRT modality was CVVHDF (88.9%). The main indications for initiation were overload (38.9%) and anuria (44.4%). There were no differences between population characteristics or RRT modality. Differences in mortality were evident, probably explained by the greater severity of the patients, as evidenced by the more excellent SOFA upon admission (P=0.001). Conclusion: Patients who were unable to disconnect from the replacement therapy program had higher mortality. The factor that most contributed to this outcome was a higher SOFA score.
- 6 June 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (2) , 175-182
Open AccessFactores asociados a falla en la desconexión de pacientes con terapia de reemplazo renal continuo.
Introduction: Critically ill patients who survive a severe episode of Acute Kidney Injury (AKI) recover sufficient renal function to allow withdrawal of Renal Replacement Therapy (RRT). However, the criteria for deciding its withdrawal need to be standardized in clinical practice. The study aimed to determine the factors associated with failure to disconnect in patients on continuous renal replacement therapy. Methods: This observational study was carried out in adult patients hospitalized in the intensive care service of the National Institute of Nutrition "Salvador Zubirán" in Mexico between October and December 2023 who required continuous renal replacement therapy. Retrospective data were collected, including demographic characteristics, comorbidities, type of renal replacement therapy, and clinical outcome. The SOFA score was used to assess disease severity. Results: A total of 18 patients were analyzed, 14 with unsuccessful disconnection and 4 with successful disconnection, with an average stay of 14±8 days in the ICU; 72% were men, 44% with a history of diabetes, and 72.2% with a history of high blood pressure. A total of 94.4% with vasopressor requirement and invasive mechanical ventilation. The primary RRT modality was CVVHDF (88.9%). The main indications for initiation were overload (38.9%) and anuria (44.4%). There were no differences between population characteristics or RRT modality. Differences in mortality were evident, probably explained by the greater severity of the patients, as evidenced by the more excellent SOFA upon admission (P=0.001). Conclusion: Patients who were unable to disconnect from the replacement therapy program had higher mortality. The factor that most contributed to this outcome was a higher SOFA score.
- Open Access
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 72-80
Nefropatía inducida por Ácido Aristolóquico.
Introduction: Aristolochic acids contain a carboxylic nitro phenanthrene group and can be found in medicinal herbs of the genus Aristolochia. Their nephrotoxicity has been confirmed in endemic geographic areas such as the Balkans of Europe and the Central American region. The clinical findings consist of tubulointerstitial nephropathy and generally go unnoticed until the advanced stages of chronic kidney disease. Objective of the review: The aim is to describe the main pathophysiological aspects and establish diagnostic and treatment criteria in patients with Aristolochic Acid Nephropathy. Essential points of the review: About 180 types of aristolochic acids (AAs) have been discovered, the most critical types AAΙ, AAΙΙ, AAΙΙΙa (AA C) and AAΙVa (AA D), which are differentiated according to the position of their hydroxyl radical (OH), hydrogen (H) and methoxyl (OCH3). AA-induced nephropathy occurs through at least five pathways that associate the depletion of intracellular glutathione, cellular damage due to induction of cell apoptosis, direct damage to the endoplasmic reticulum, and mitochondrial damage. This produces atrophic tubular injury and interstitial fibrosis; the metabolite has a bladder neoplastic effect. Conclusion: The incidence of aristolochic acid nephropathy is probably much higher than initially thought, and its existence should be considered in patients who present with chronic kidney disease with a tubulo-interstitial clinical pattern.
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 72-80
Open AccessNefropatía inducida por Ácido Aristolóquico.
Introduction: Aristolochic acids contain a carboxylic nitro phenanthrene group and can be found in medicinal herbs of the genus Aristolochia. Their nephrotoxicity has been confirmed in endemic geographic areas such as the Balkans of Europe and the Central American region. The clinical findings consist of tubulointerstitial nephropathy and generally go unnoticed until the advanced stages of chronic kidney disease. Objective of the review: The aim is to describe the main pathophysiological aspects and establish diagnostic and treatment criteria in patients with Aristolochic Acid Nephropathy. Essential points of the review: About 180 types of aristolochic acids (AAs) have been discovered, the most critical types AAΙ, AAΙΙ, AAΙΙΙa (AA C) and AAΙVa (AA D), which are differentiated according to the position of their hydroxyl radical (OH), hydrogen (H) and methoxyl (OCH3). AA-induced nephropathy occurs through at least five pathways that associate the depletion of intracellular glutathione, cellular damage due to induction of cell apoptosis, direct damage to the endoplasmic reticulum, and mitochondrial damage. This produces atrophic tubular injury and interstitial fibrosis; the metabolite has a bladder neoplastic effect. Conclusion: The incidence of aristolochic acid nephropathy is probably much higher than initially thought, and its existence should be considered in patients who present with chronic kidney disease with a tubulo-interstitial clinical pattern.
- Open Access
- 24 January 2024
- Published by Asociacion Colombiana de Nefrologia e Hipertension Arterial in Revista Colombiana de Nefrología
- Vol. 11 (1)
Living on High Altitudes Associated with Reduced Requirements of Exogenous Erythropoietin in Patients on Chronic Hemodialysis
Introduction: During the last decades the use of erythropoiesis stimulating agents has significantly diminished the prevalence of anemia in patients receiving chronic hemodialysis. Currently, residing at higher altitudes is associated with higher levels of endogenous erythropoietin. Objective: This study aims to analyze how residing at higher altitudes influences the requirements of exogenous erythropoietin in patients receiving hemodialysis as renal replacement therapy. Methodology: Descriptive observational cross-section, including adult patients from three Ecuadorian centers, receiving chronic hemodialysis, between January and June 2020. Patients were classified into two groups regarding the altitude of residence: those living at low-lying regions (2000 masl, Quito). Results: We included 580 patients, 45.5% in the high-altitude group and 54.5% at low-lying regions. Median exogenous erythropoietin dose was higher in low-lying regions (22000 international units) versus high altitude (17333.3 international units) (P=0.00003) and the proportion of patients without erythropoietin requirement was higher in high altitude (21.6%), compared to low regions (1.0%) (P<0.01). The multivariate analysis associated residing in low regions (HR 58.9, P<0.01), age (HR 0.98, P=0.03) and Kt/V (HR 38.5, P<0.01) with higher exogenous erythropoietin requirements. Additionally, among patients who required erythropoietin, residing in lower altitudes was linked with a need for exogenous erythropoietin doses exceeding 15000 international units per week (HR 1.92, P=0.001). Conclusion: In Ecuadorian patients receiving hemodialysis, living at high altitude is associated with a reduced requirement of exogenous erythropoietin compared with those patients residing in low-lying regions.
- 24 January 2024
- Published by Asociacion Colombiana de Nefrologia e Hipertension Arterial in Revista Colombiana de Nefrología
- Vol. 11 (1)
Open AccessLiving on High Altitudes Associated with Reduced Requirements of Exogenous Erythropoietin in Patients on Chronic Hemodialysis
Introduction: During the last decades the use of erythropoiesis stimulating agents has significantly diminished the prevalence of anemia in patients receiving chronic hemodialysis. Currently, residing at higher altitudes is associated with higher levels of endogenous erythropoietin. Objective: This study aims to analyze how residing at higher altitudes influences the requirements of exogenous erythropoietin in patients receiving hemodialysis as renal replacement therapy. Methodology: Descriptive observational cross-section, including adult patients from three Ecuadorian centers, receiving chronic hemodialysis, between January and June 2020. Patients were classified into two groups regarding the altitude of residence: those living at low-lying regions (2000 masl, Quito). Results: We included 580 patients, 45.5% in the high-altitude group and 54.5% at low-lying regions. Median exogenous erythropoietin dose was higher in low-lying regions (22000 international units) versus high altitude (17333.3 international units) (P=0.00003) and the proportion of patients without erythropoietin requirement was higher in high altitude (21.6%), compared to low regions (1.0%) (P<0.01). The multivariate analysis associated residing in low regions (HR 58.9, P<0.01), age (HR 0.98, P=0.03) and Kt/V (HR 38.5, P<0.01) with higher exogenous erythropoietin requirements. Additionally, among patients who required erythropoietin, residing in lower altitudes was linked with a need for exogenous erythropoietin doses exceeding 15000 international units per week (HR 1.92, P=0.001). Conclusion: In Ecuadorian patients receiving hemodialysis, living at high altitude is associated with a reduced requirement of exogenous erythropoietin compared with those patients residing in low-lying regions.
- Open Access
- 15 August 2023
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 11 (2) , 117-119
Sobrevida y desigualdad social en adultos mayores con enfermedad renal crónica estadio 5 en tratamiento de hemodiálisis.
Introducción: El acceso de adultos mayores a programas de hemodiálisis es cada vez mas frecuente. El objetivo de este estudio fue determinar la sobrevida de los adultos mayores con Enfermedad Renal Crónica (ERC) estadio 5 en Hemodiálisis, posterior a 5 años de seguimiento, en relación con la desigualdad social, y las características clínicas, bioquímicas y funcionales de la población estudiada. Métodos: El presente estudio observacional, analítico, de fuente retrospectiva, se realizó en el Centro Nefrológico CLINEF Norte, en Quito, Ecuador, en el período 2007-2012. Se incluyeron pacientes >64 años, con ERC 5-d. Se registraron variables clínicas, nutricionales, economicas, sociodemográficas, mortalidad y sobrevida global (SG). La muestra fue no probabilística. Se midió sobrevida a los 5 años con Kaplan-Meier y se analizó la asociación entre las variables. Resultados: Se analizan 71 casos, con edad de 70.7 ± 6.6 años, 64.8 % hombres, 49.3 % con ingreso < 530 dólares. La SG a los 5 años fue de 48.9 %. Las variables que se asociaron significativamente con la SG fueron: sexo masculino (SG 49.0 ± 2.4 meses, P=0.010), ausencia de ECV con SG 45.3 ± 2.4 meses, P=0.010), albúmina > 3.51 g/dl (SG 49.7 ± 2.9 meses, P =0.009), Karnofsky > 80 ( SG 52.7 ± 2.2 meses, P=0.002). El sexo femenino y antecedente de ECV presentaron un HR estadísticamente significativo (HR 2.29, IC 95% 1.18 -4.43; HR 2.67, IC 95% 1.21-5.88). Al ajustar por ingreso económico bajo, junto al sexo femenino y albúmina baja, mantuvieron su asociación (HR 2.21, IC 95% 1.01-4.82), (P=0.044). Conclusión: El estado nutricional y la valoración funcional fueron los principales factores asociados a mayor sobrevida del adulto mayor en hemodiálisis. En un subanalisis se demostró que las mujeres con ingreso económico bajo tienen menor supervivencia.
- 15 August 2023
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 11 (2) , 117-119
Open AccessSobrevida y desigualdad social en adultos mayores con enfermedad renal crónica estadio 5 en tratamiento de hemodiálisis.
Introducción: El acceso de adultos mayores a programas de hemodiálisis es cada vez mas frecuente. El objetivo de este estudio fue determinar la sobrevida de los adultos mayores con Enfermedad Renal Crónica (ERC) estadio 5 en Hemodiálisis, posterior a 5 años de seguimiento, en relación con la desigualdad social, y las características clínicas, bioquímicas y funcionales de la población estudiada. Métodos: El presente estudio observacional, analítico, de fuente retrospectiva, se realizó en el Centro Nefrológico CLINEF Norte, en Quito, Ecuador, en el período 2007-2012. Se incluyeron pacientes >64 años, con ERC 5-d. Se registraron variables clínicas, nutricionales, economicas, sociodemográficas, mortalidad y sobrevida global (SG). La muestra fue no probabilística. Se midió sobrevida a los 5 años con Kaplan-Meier y se analizó la asociación entre las variables. Resultados: Se analizan 71 casos, con edad de 70.7 ± 6.6 años, 64.8 % hombres, 49.3 % con ingreso < 530 dólares. La SG a los 5 años fue de 48.9 %. Las variables que se asociaron significativamente con la SG fueron: sexo masculino (SG 49.0 ± 2.4 meses, P=0.010), ausencia de ECV con SG 45.3 ± 2.4 meses, P=0.010), albúmina > 3.51 g/dl (SG 49.7 ± 2.9 meses, P =0.009), Karnofsky > 80 ( SG 52.7 ± 2.2 meses, P=0.002). El sexo femenino y antecedente de ECV presentaron un HR estadísticamente significativo (HR 2.29, IC 95% 1.18 -4.43; HR 2.67, IC 95% 1.21-5.88). Al ajustar por ingreso económico bajo, junto al sexo femenino y albúmina baja, mantuvieron su asociación (HR 2.21, IC 95% 1.01-4.82), (P=0.044). Conclusión: El estado nutricional y la valoración funcional fueron los principales factores asociados a mayor sobrevida del adulto mayor en hemodiálisis. En un subanalisis se demostró que las mujeres con ingreso económico bajo tienen menor supervivencia.
- Open Access
- 8 September 2022
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 10 (2) , 97-107
Obesidad y enfermedad renal crónica. Una mirada desde los mecanismos fisiopatológicos.
Introduction: Chronic kidney disease associated with obesity (CKD-WO) has increased in prevalence in recent decades. It is characterized by excess adipocytic hormonal imbalances (adipokines), deregulation of the energy balance system, and imbalances in metabolic homeostasis. Purpose of the review: The objective is to outline the different pathophysiological mechanisms' role in developing functional or anatomical kidney disease in obese patients. We look for updated reports that include the best survival results for patients with CKD. Recent findings: We currently know that CKD-WO has a chronic pro-inflammatory behavior. Obesity and overweight are associated with hemodynamic, structural, and histopathological alterations in the kidney and metabolic and biochemical alterations that predispose to kidney disease, even when renal function and conventional tests are normal. Conclusions: We classify CKD-WO in Type 1: Obesity and potentially reversible functional alterations. Type 2: Obesity and potentially non-reversible histopathological structural alterations (includes glomerulopathy associated with obesity and focal segmental glomerulosclerosis). Type 3: Obesity-related to chronic diseases (diabetes, hypertension, pulmonary hypertension, heart failure). Type 4: Obesity in the patient with renal function replacement therapy.
- 8 September 2022
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 10 (2) , 97-107
Open AccessObesidad y enfermedad renal crónica. Una mirada desde los mecanismos fisiopatológicos.
Introduction: Chronic kidney disease associated with obesity (CKD-WO) has increased in prevalence in recent decades. It is characterized by excess adipocytic hormonal imbalances (adipokines), deregulation of the energy balance system, and imbalances in metabolic homeostasis. Purpose of the review: The objective is to outline the different pathophysiological mechanisms' role in developing functional or anatomical kidney disease in obese patients. We look for updated reports that include the best survival results for patients with CKD. Recent findings: We currently know that CKD-WO has a chronic pro-inflammatory behavior. Obesity and overweight are associated with hemodynamic, structural, and histopathological alterations in the kidney and metabolic and biochemical alterations that predispose to kidney disease, even when renal function and conventional tests are normal. Conclusions: We classify CKD-WO in Type 1: Obesity and potentially reversible functional alterations. Type 2: Obesity and potentially non-reversible histopathological structural alterations (includes glomerulopathy associated with obesity and focal segmental glomerulosclerosis). Type 3: Obesity-related to chronic diseases (diabetes, hypertension, pulmonary hypertension, heart failure). Type 4: Obesity in the patient with renal function replacement therapy.
- Open Access
- 28 February 2022
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 10 (1) , 1-8
Older adults: Kidney disease or senescent aging? HUGE vs. CKD-EPI scale. The approach to the elderly.
Introduction: The approach to the renal condition of older people requires diagnostic tools for this age group, which allow for discerning the renal condition between chronicity and senescence. This research aimed to analyze whether the HUGE scale is a companion tool to determine the existence of chronic kidney disease in older adult patients seen in outpatient clinics. Methods: This observational, analytical, and cross-sectional study was carried out in the Specialty Hospital of the Armed Forces No. 1 nephrology outpatient clinic from 2015 to 2018. Results: We included 285 patients. The prevalence of chronic kidney disease was higher in people older than 75 years (60.7%). With the HUGE formula, a lower proportion of chronic kidney disease was established in 37% of men and 60% of women (P = 0.002) than in the CKD-EPI formula (83% and 89%, respectively). The specificity achieved by the HUGE formula was higher than the CKD-EPI and MDRD formulas (97% vs. 80% vs. 79%, respectively), having the highest discriminative capacity (NPV 70%). Hyperuricemia and diabetes mellitus are associated with the development of chronic kidney disease. Conclusions: This research showed that the HUGE formula helps discern older adults with decreased glomerular filtration due to senescent aging in those with kidney disease. In addition, the HUGE formula is recommended as a complementary tool in the approach to chronic kidney disease in older adults.
- 28 February 2022
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 10 (1) , 1-8
Open AccessOlder adults: Kidney disease or senescent aging? HUGE vs. CKD-EPI scale. The approach to the elderly.
Introduction: The approach to the renal condition of older people requires diagnostic tools for this age group, which allow for discerning the renal condition between chronicity and senescence. This research aimed to analyze whether the HUGE scale is a companion tool to determine the existence of chronic kidney disease in older adult patients seen in outpatient clinics. Methods: This observational, analytical, and cross-sectional study was carried out in the Specialty Hospital of the Armed Forces No. 1 nephrology outpatient clinic from 2015 to 2018. Results: We included 285 patients. The prevalence of chronic kidney disease was higher in people older than 75 years (60.7%). With the HUGE formula, a lower proportion of chronic kidney disease was established in 37% of men and 60% of women (P = 0.002) than in the CKD-EPI formula (83% and 89%, respectively). The specificity achieved by the HUGE formula was higher than the CKD-EPI and MDRD formulas (97% vs. 80% vs. 79%, respectively), having the highest discriminative capacity (NPV 70%). Hyperuricemia and diabetes mellitus are associated with the development of chronic kidney disease. Conclusions: This research showed that the HUGE formula helps discern older adults with decreased glomerular filtration due to senescent aging in those with kidney disease. In addition, the HUGE formula is recommended as a complementary tool in the approach to chronic kidney disease in older adults.